Eckol treatment effectively reduced the sphere formation, CD133+ cell population and concealed the expression of glioma stem-like cell markers and self-renewal-related proteins in the absence of cell death.The fusion of eckol with glioma stem-like cells diminished tumor formation and the anchorage-independent growth of cells on soft agar in xenograft mice. This evidence concerns the gene PROM1 and glioma.